Carbon, a Silicon Valley-based digital manufacturing company, announced the launch of its first medical-grade material: Medical Polyurethane 100 (MPU 100). This white polymer resin offers mechanical strength, biocompatibility and sterilizability, making it suitable for components of medical systems, skin-contact devices, drug-contact devices, and single-use medical device applications.
With the growing need for medical tools that are easy to produce, versatile, and also strong and durable enough to withstand demanding medical environments, MPU 100 can be used to produce end-use parts such as complex adaptors for diagnostic analysis systems, textured instrument handles, single use instruments, and bioprocessing components. In each of these applications, designers can incorporate better user experiences through complex geometries and textured surfaces, consolidate multi-part assemblies, and pursue low-volume, high-mix part production. By combining the high performance of MPU 100 with Carbon’s Digital Light Synthesis technology, medical device manufacturers and life sciences companies can accelerate product development for critical devices and components.
Key features of MPU 100 include:
–Engineering-grade material with excellent abrasion resistance
–Tested to USP VI and ISO 10993-5 and -10 biocompatibility
–Compatible with ethylene oxide, e-beam, and gamma sterilization methods
–Maintains its biocompatibility post-sterilization
–Compatible with common disinfectants
–Certificate of Analysis available
–Master file available with FDA
MPU 100 is offered only in 800ML cartridges to Carbon customers in the U.S., Canada, and Europe.